Background: Patients with attention deficit/hyperactivity disorder (ADHD) often experience comorbid conditions, such as autism spectrum disorder (ASD) and Tourette syndrome (TS). Although pharmacotherapies are effective for treating ADHD, they are likely to elicit a variety of adverse effects. It is, thus, important to select an effective and well-tolerated pharmacotherapeutic treatment for patients with ADHD/ASD comorbid with TS.
Case presentation: We report the case of a 10-year-old boy with ADHD/ASD comorbid with TS who was treated with guanfacine (GUAN). He experienced several side effects of atomoxetine (ATX) and methylphenidate (MPH) before being treated with GUAN. In the presented case, symptoms of ADHD as well as tic symptoms were improved by treatment with GUAN.
Conclusion: GUAN might be effective and well tolerated in the treatment of patients with ADHD/ASD comorbid with TS who experience side effects of ATX and MPH.
Keywords: Atomoxetine; Attention deficit/hyperactivity disorder; Autism spectrum disorder; Guanfacine; Methylphenidate; Tourette syndrome.
Tourette Syndrome and comorbid ADHD: current pharmacological treatment options.Eur J Paediatr Neurol. 2013 Sep;17(5):421-8. doi: 10.1016/j.ejpn.2013.01.005. Epub 2013 Mar 7. Eur J Paediatr Neurol. 2013. PMID: 23473832 Review.
Pharmacological treatment for Attention Deficit Hyperactivity Disorder (ADHD) in children with comorbid tic disorders.Cochrane Database Syst Rev. 2011 Apr 13;(4):CD007990. doi: 10.1002/14651858.CD007990.pub2. Cochrane Database Syst Rev. 2011. PMID: 21491404 Updated. Review.
Attention-deficit/Hyperactivity Disorder in the context of Autism spectrum disorders.Curr Psychiatry Rep. 2010 Oct;12(5):382-8. doi: 10.1007/s11920-010-0145-3. Curr Psychiatry Rep. 2010. PMID: 20694583 Review.
Efficacy of atomoxetine in the treatment of attention-deficit hyperactivity disorder in patients with common comorbidities in children, adolescents and adults: a review.Ther Adv Psychopharmacol. 2016 Oct;6(5):317-334. doi: 10.1177/2045125316647686. Epub 2016 May 20. Ther Adv Psychopharmacol. 2016. PMID: 27721971 Free PMC article. Review.
Shared Brain Connectivity Issues, Symptoms, and Comorbidities in Autism Spectrum Disorder, Attention Deficit/Hyperactivity Disorder, and Tourette Syndrome.Brain Connect. 2015 Aug;5(6):321-35. doi: 10.1089/brain.2014.0324. Epub 2015 Apr 14. Brain Connect. 2015. PMID: 25602622 Review.
- Scahill L, Schwab-Stone M. Epidemiology of ADHD in school-age children. Child Adolesc Psychiatr Clin. 2000;9(3):541–555. - PubMed
- Biederman J, Faraone SV. Attention-deficit hyperactivity disorder. Lancet. 2005;366(9481):237–248. - PubMed
- Frazier JA, Biederman J, Bellordre CA, Garfield SB, Geller DA, Coffey BJ, et al. Should the diagnosis of attention-deficit/hyperactivity disorder be considered in children with pervasive developmental disorder? J Atten Disord. 2001;4(4):203–211.
- Yoshida Y, Uchiyama T. The clinical necessity for assessing Attention Deficit/Hyperactivity Disorder (AD/HD) symptoms in children with high-functioning pervasive developmental disorder (PDD) Eur Child Adolesc Psychiatry. 2004;13(5):307–314. - PubMed
- Jensen CM, Steinhausen HC. Comorbid mental disorders in children and adolescents with attention-deficit/hyperactivity disorder in a large nationwide study. Atten Defic Hyperact Disord. 2015;7(1):27–38. - PubMed